These pages are best viewed with Netscape version 3.0 or higher or
Internet Explorer version 3.0 or higher. When viewed with other browsers, some characters
or attributes may not be rendered correctly.
CONTENTS
Volume 15, Number 2
March/April 1997 |
| Editorial: The Complication Most Often Overlooked |
46 |
| Feature: Insulin Lispro: The Next Step |
51 |
| Feature: Troglitazone: A New and Unique Oral Anti-Diabetic Agent for
the Treatment of Type II Diabetes and the Insulin Resistance Syndrome. |
60 |
Copyright © 1998 American Diabetes Association
Updated 10/98
|